Laurent Mailly

Strasbourg, 67000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models.

Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models.

Journal: Science translational medicine

Published: June 03, 2026

Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease.

Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease.

Journal: eGastroenterology

Published: October 30, 2024

Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis.

Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis.

Journal: Journal of hepatology

Published: September 13, 2024

Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease models.

Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease models.

Journal: The Journal of clinical investigation

Published: February 02, 2023

A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity.

A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity.

Journal: Science translational medicine

Published: December 21, 2022

Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment.

Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment.

Journal: Journal of hepatology

Published: February 21, 2022

The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells.

The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells.

Journal: bioRxiv : the preprint server for biology

Published: March 24, 2021

The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells.

The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells.

Journal: iScience

Published: January 06, 2021

Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target.

Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target.

Journal: Gut

Published: November 19, 2020

Circadian control of hepatitis B virus replication.

Circadian control of hepatitis B virus replication.

Journal: Nature communications

Published: June 07, 2020

Hypoxia inducible factors regulate hepatitis B virus replication by activating the basal core promoter.

Hypoxia inducible factors regulate hepatitis B virus replication by activating the basal core promoter.

Journal: Journal of hepatology

Published: April 30, 2020

Hepatitis C virus infection and tight junction proteins: The ties that bind.

Hepatitis C virus infection and tight junction proteins: The ties that bind.

Journal: Biochimica et biophysica acta. Biomembranes

Published: January 13, 2020

Showing 1-12 of 30

Last Updated: 09/26/2026